• Nachrichtendetail
• 

27.02.2024 13:15:34 - dpa-AFX: *LIGAND PHARMA Q4 EPS $1.03 VS LOSS/SHR $1.04 PRIOR YEAR

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	90,000	12.07.24 08:56:55	+1,500	+1,69%	89,500	90,500	90,000	88,500